Competitive Technologies Licenses Enterovirus Assay Technology to Focus Diagnostics
Fairfield, CT - (April 13, 2007) - Competitive Technologies, Inc. (AMEX: CTT) announced today that Focus Diagnostics, Inc. will be producing enterovirus assay kits under the recently expanded license granted to them for the use of the patented technology for the Rapid Assay of Human Enteroviruses (US Patent 5,075,212). The technology is the result of research by Dr. Harley A. Rotbart conducted at the University of Colorado (UC), a CTT client. The agreement provides commercialization and recurring royalty fees for both UC and CTT.
"This agreement is another example of a CTT technology fulfilling consumer needs," said John B. Nano, CTT's Chairman, President and CEO. "We are actively marketing our technology portfolio, including nutraceutical ingredients, HB LED technology, bone biomaterial, cholesterol trapping/regeneration technology, Lupus diagnostic and monitoring technology, and the RFID tracking system, to produce a recurring revenue stream and create shareholder value."
Dr. Rotbart is a Professor of Pediatrics and Microbiology at UC's Health Sciences Center, and Vice Chair of Academic Affairs. The assay detects enteroviruses, also known as poliovirus, coxsackeviruses and echoviruses, in biological tissue. These viruses are responsible for millions of infections each year, and have been implicated as possible causes in aseptic meningitis, conjunctivitis, diabetes, inflammatory muscle disease, and chronic fatigue syndrome.
About Focus Diagnostics, Inc.
Focus Diagnostics, Inc. is an infectious disease diagnostics company, providing reference laboratory services to hospitals and laboratories nationwide and manufacturing and distributing diagnostic products worldwide. Focus Diagnostics develops innovative products for diagnosing infectious diseases, and often provides the first commercially available diagnostic tests in the U.S. for emerging diseases such as West Nile Virus and SARS. Focus Diagnostics was acquired in July 2006 by Quest Diagnostics, and is a wholly owned subsidiary of Quest Diagnostics, Incorporated. Visit www.focusdx.com for additional information.
About Competitive Technologies
Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions. CTT is a global leader in identifying, developing and commercializing innovative technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: http://www.competitivetech.net
Statements about our future expectations, including development and regulatory plans, and all other statements in this document, other than historical facts, are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. If and when used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions, as they relate to us or our business or management, are intended to identify such forward-looking statements. These statements involve risks and uncertainties related to our ability to obtain rights to market technologies, market acceptance of and competition for our licensed technologies, growth strategies and strategic plans, operating performance and financing of our operations, industry trends, and other risks and uncertainties inherent in our business, including those set forth in Item 1A under the caption "Risk Factors," in our most recent Annual Report on Form 10-K for the year ended July 31, 2006, filed with the Securities and Exchange Commission (SEC) on October 30, 2006, and other factors that may be described in our other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.
IR Services, LLC
Tel: 860.434.2465
Email: This email address is protected, Javascript must be enabled to view it
